Odds of FIT-based screening lower with suppression subdomains of ‘deny immediacy to be tested’ and ‘self-exemption’
TUESDAY, Feb. 7, 2023 (HealthDay News) — Defensive information processing (DIP) is a barrier to colorectal cancer screening uptake, according to a study published online Feb. 6 in Cancer.
Nicholas Clarke, Ph.D., from Dublin City University in Ireland, and colleagues examined the correlation of DIP with fecal immunochemical test (FIT)-based colorectal cancer screening uptake using data from a cross-sectional survey within a population-based FIT screening program. The seven subdomains of the McQueen DIP measure were included in the survey, and their correlation with screening uptake status was assessed.
The researchers found that in a model adjusted for sociodemographic factors, there was a significant correlation for higher scores on all DIP domains, equating to greater defensiveness, with lower uptake of screening. The suppression subdomains of “deny immediacy to be tested” and “self-exemption” independently predicted nonuse of FIT-based screening in the model with additional adjustments for behavioral factors (odds ratios, 0.53 and 0.80, respectively).
“Suppressors who deny the immediacy to be screened may be amenable to behavioral interventions that nudge them to be screened. Suppressors who selfâ€exempt themselves may require stronger educational and defensivenessâ€reducing interventions to encourage future screening participation,” the authors write.
Several authors disclosed financial ties to the biopharmaceutical and medical device industries.
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Family History of CRC Increases CRC Risk Similarly in IBD, General Population
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD
Gene Mutation Identified That Increases Lung Cancer Risk
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50